COVID-19 and modern pediatric practice


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The pandemic of a new severe infection, announced by the World Health Organization last year, continues to develop. To a certain extent, the epidemic has affected the child population. For the first time, pediatricians are faced with the incredible situation where adults are more severely ill than children. However, children were not left out of the spread of COVID-19. The article summarizes the results of developments concerning the development of a new disease, its diagnosis, therapeutic possibilities with the use of modern medicines. Most of the information regarding the impact of the novel coronavirus on children is still in clinical trials and is on the way to being introduced into pediatric practice.

Full Text

Restricted Access

About the authors

L. A Kharitonova

N.I. Pirogov Russian National Research Medical University, Russian Health Ministry

O. N Solodovnikova

N.I. Pirogov Russian National Research Medical University, Russian Health Ministry

A. A Ploskireva

N.I. Pirogov Russian National Research Medical University, Russian Health Ministry; Central Research Institute of Epidemiology, Federal Service on Customers’ Rights Protection and Human Well-being Surveillance

T. V Sbrodova

N.I. Pirogov Russian National Research Medical University, Russian Health Ministry

K. I Grigoriev

N.I. Pirogov Russian National Research Medical University, Russian Health Ministry

Email: k-i-grigoryev@yandex.ru

References

  1. Бабанов С.А., Штейнер М.Л., Биктагиров Ю.И., Жестков А.В., Стрижаков Л.А., Острякова Н.А., Агаркова А.С., Кирюшина Т.М. Потенциальные эпидемические риски и их учет при проведении эндоскопических исследований в условиях COVID-госпиталя. Врач, 2021; 2 (32): 47-52 https://doi.org/10.29296/25877305-2021-02-09
  2. Гоми Р., Асгари Н., Хаджихейдари А., Эстеки Р., Байбанаки Ф., Насиринасаб Ф. Пандемия COVID-19: систематический обзор современных данных. Инфекция и иммунитет. 2020;10(4):655-663.https://doi. org/ 10.15789/2220-7619-TCP-1508
  3. Каледа М.И., Никишина И.П., Федоров Е.С., Насонов Е.Л. Коронавирусная болезнь 2019 (COVID-19) у детей: уроки педиатрической ревматологии. Научнопрактическая ревматология. 2020;58(5):469-479. https://doi.org/10.47360/1995-4484-2020-469-479
  4. Министерство здравоохранения РФ. Методические рекомендации: Особенности клинических проявлений и лечения заболевания, вызванного новой коронавирусной инфекцией (COVID-19) у детей. Версия 2 (03.07.2020). Доступно на: https://static-0.minzdrav.gov. ru/ system/attachments/attaches/000/050/914/original/ 03062020_%D0%B4%D0%B5%D1%82%D0%B8_COVID-19_v2.pdf
  5. Мультисистемный воспалительный синдром у детей (MIS-C) [интернет]. (CDC (2020) Центры по контролю и профилактике заболеваний. https://www.cdc. gov/mis-c/hcp/
  6. Намазова-Баранова Л.С., Баранов А.А. COVID-19 и дети. Пульмонология. 2020; 30 (5): 609-628. doi: 10.18093/0869-0189-2020-30-5-609-628
  7. Пиманов С.И., Дикарева Е.А. Гастроэнтерологические проявления COVID-19: первые обобщения. Клинический разбор в общей медицине. 2020; 1: 6-13. doi: 10.47407/kr2020.1.1.00001
  8. Самородская И.В. Проблемы выбора методов лечения. Врач, 2020; 8 (31): 11-18 https://doi. org/10.29296/25877305-2020-08-02
  9. Фурман Е.Г. Коронавирусная инфекция COVID-19 и дети. Педиатрия им. Г.Н. Сперанского. 2020; 99 (3): 245-251.
  10. Cai J., Xu J., Lin D. et al. A case series of children with 2019 novel coronavirus infection: Clinical and epidemiological features. Clin. Infect. Dis. 2020; 71 (6): 1547-1551. doi: 10.1093/cid/ciaa198.
  11. Сао В., Wang Y., Wen D. et al. A trial of lopinavir-ritonavir in adults hospitalized with severe COVID-19. N Engl J Med. 2020; 382 (19): 1787-1799. DOI: 10.1056/ NEJMoa2001282
  12. Diez J.-M., Romero C., Gajardo R. Currently available intravenous immunoglobulin (Gamunex®-C and Flebogamma® DIF) contains antibodies reacting against SARS-CoV-2 antigens. bioRxiv. 2020: 029017. doi: 10.1101/2020.04.07.029017
  13. Drexler J.F., Gloza-Rausch F., Glende J., Corman V.M., Muth D., Goettsche M./Genomic characterization of severe acute respiratory syndrome-related coronavirus in European bats and classification of coronaviruses based on partial RNA-dependent RNA polymerase gene sequences. J Virol. 2010; 84(21):11336-49. doi: 10.1128/ JVI.00650-10. Epub 2010 Aug 4.
  14. Feldstein LR, Rose EB, Horwitz SM, Collins JP,Newhams MM, Son MBF идр. Мультисистемный воспалительный синдром у детей и подростков США. N Engl J Med. 2020;383(4):334-346. doi: 10.1056/ NEJMoa2021680.
  15. Grein J., Ohmagari N., Shin D. et al. Compassionate use of remdesivir for patients with severe COVID-19. N Engl J Med. 2020; 382 (24): 2327-2336. DOI: 10.1056/ NEJMoa2007016
  16. Hamre D., Procknow J.J. A new virus isolated from the human respiratory tract. Proc Soc Exp Biol Med 1966; 121(1):190-3. doi: 10.3181/00379727-121-30734
  17. Liang W., Feng Z., Rao S., Xiao C., Xue X., Lin Z., Zhang Q., Qi W. Диарея может быть недооценена: недостающее звено в новом коронавирусе 2019 года. Gut. 2020; 69:1141-1143.
  18. Rojas M., Rodriguez Y., Monsalve D.M., et al. Convalescent plasma in Covid-19: Possible mechanisms of action. Autoimmun Rev. 2020; 19(7):102554. doi: 10.1016/j.autrev.2020.102554
  19. Song Z., Xu Y., Bao L., Zhang L., Yu P., Qu Y. From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses. 2019; 11(1): 59. doi: 10.3390/v11010059
  20. Van der Hoek L., Pyrc K., Jebbink M.F., Vermeulen-Oost W., Berkhout R.J., Wolthers K.C. Identification of a new human coronavirus. Nat Med. 2004; 10(4): 368-73. doi: 10.1038/nm1024. Epub 2004 Mar 21.
  21. Van Doremalen N., Bushmaker T., Morris D.H. et al. Aerosol and surface stability of Sars-Cov-2 as compared with Sars-Cov-1. N Engl J Med. 2020; 382 (16): 15641567. doi: 10.1056/NEJMc2004973
  22. WHO. Multisystem inflammatory syndrome in children and adolescents with COVID-19. URL: https:// www.who.int/publications/i/item/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19 (Date accessed: 2020).
  23. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3
  24. Zou L., Ruan F., Huang M. et al. Sars-Cov-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020; 382 (12): 1177-1179. DOI: 10.1056/ NEJMc 2001737
  25. Zhu H., Wang L., Fang C. et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl. Pediatr. 2020; 9 (1): 51-60. DOI: 10.21037/ tp.2020.02.06.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies